EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Variations of Three Kazakhstan Strains of the SARS-CoV-2 Virus

Bekbolat Usserbayev iD, Kulyaisan T Sultankulova, Yerbol Burashev iD, Aibarys Melisbek, Meirzhan Shirinbekov, Balzhan S Myrzakhmetova, Asankadir Zhunushov, Izat Smekenov, Aslan Kerimbaev, Sergazy Nurabaev, Olga Chervyakova iD, Nurlan Kozhabergenov iD und 1 weitere

Viruses · 2025

DOI: 10.3390/v17030415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Bekbolat Usserbayev und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Genetic Variation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Development of a vaccine against coronavirus infection COVID-19, Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prompt determination of the etiological agent is important in an outbreak of pathogens with pandemic potential, particularly for dangerous infectious diseases. Molecular genetic methods allow for arriving at an accurate diagnosis, employing timely preventive measures, and controlling the spread of the disease-causing agent. In this study, whole-genome sequencing of three SARS-CoV-2 strains was performed using the Sanger method, which provides high accuracy in determining nucleotide sequences and avoids errors associated with multiple DNA amplification. Complete nucleotide sequences of samples, KAZ/Britain/2021, KAZ/B1.1/2021, and KAZ/Delta020/2021 were obtained, with sizes of 29.751 bp, 29.815 bp, and 29.840 bp, respectively. According to the COVID-19 Genome Annotator, 127 mutations were detected in the studied samples compared to the reference strain. The strain KAZ/Britain/2021 contained 3 deletions, 7 synonymous mutations, and 27 non-synonymous mutations, the second strain KAZ/B1.1/2021 contained 1 deletion, 5 synonymous mutations, and 31 non-synonymous mutations, and the third strain KAZ/Delta020/2021 contained 1 deletion, 5 synonymous mutations, and 37 non-synonymous mutations, respectively. The variations C241T, F106F, P314L, and D614G found in the 5′ UTR, ORF1ab, and S regions were common to all three studied samples, respectively. According to PROVEAN data, the loss-of-function mutations identified in strains KAZ/Britain/2021, KAZ/B1.1/2021, and KAZ/Delta020/2021 include 5 mutations (P218L, T716I, W149L, R52I, and Y73C), 2 mutations (S813I and Q992H), and 8 mutations (P77L, L452R, I82T, P45L, V82A, F120L, F120L, and R203M), respectively. Phylogenetic analysis showed that the strains studied (KAZ/Britain/2021, KAZ/B1.1/2021, and KAZ/Delta020/2021) belong to different SARS-CoV-2 lineages, which are closely related to samples from Germany (OU141323.1 and OU365922.1), Mexico (OK432605.1), and again Germany (OV375251.1 and OU375174.1), respectively. The nucleotide sequences of the studied SARS-CoV-2 virus strains were registered in the Genbank database with the accession numbers: ON692539.1, OP684305, and OQ561548.1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Genetic VariationGenome, ViralHumansPhylogenyWhole Genome SequencingKazakhstanMutation

Stichwörter der Autor:innen

COVID-19Sanger methodgenome sequencingmutationphylogenetic analysis

Autor:innen und Institutionen

  • Research Institute for Biological Safety Problems, National Holding QazBioPharm, LLP, Guardeyskiy uts 080409, Kazakhstan.
  • Institute of Biotechnology, National Academy of Science of Kyrgyzstan, Bishkek 720071, Kyrgyzstan.
  • Scientific Research Institute of Biology and Biotechnology Problems, al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.

ORCID-Profile: Bekbolat Usserbayev, Yerbol Burashev, Olga Chervyakova, Nurlan Kozhabergenov

Förderung

  • Development of a vaccine against coronavirus infection COVID-19
  • Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan

Zitieren

APA

Usserbayev, B., Sultankulova, K. T., Burashev, Y., Melisbek, A., Shirinbekov, M., Myrzakhmetova, B. S., Zhunushov, A., Smekenov, I., Kerimbaev, A., Nurabaev, S., Chervyakova, O., Kozhabergenov, N., & Kutumbetov, L. B. (2025). Genetic Variations of Three Kazakhstan Strains of the SARS-CoV-2 Virus. Viruses. https://doi.org/10.3390/v17030415

Vancouver

Usserbayev B, Sultankulova KT, Burashev Y, Melisbek A, Shirinbekov M, Myrzakhmetova BS, et al. Genetic Variations of Three Kazakhstan Strains of the SARS-CoV-2 Virus. Viruses. 2025. doi:10.3390/v17030415

BibTeX
@article{Usserbayev2025,
  author = {Usserbayev, Bekbolat and Sultankulova, Kulyaisan T and Burashev, Yerbol and Melisbek, Aibarys and Shirinbekov, Meirzhan and Myrzakhmetova, Balzhan S and Zhunushov, Asankadir and Smekenov, Izat and Kerimbaev, Aslan and Nurabaev, Sergazy and Chervyakova, Olga and Kozhabergenov, Nurlan and Kutumbetov, Lesbek B},
  title = {Genetic Variations of Three Kazakhstan Strains of the SARS-CoV-2 Virus},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17030415}
}
Kostenlos starten →